Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine in Head and Neck Cancer Radiation Treatment
NCT01288625Phase 4Withdrawn
- Sponsor
- Sun Pharma
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of amifostine in oral mucositis (OM), stomatitis, sponsored by Sun Pharma. Status: withdrawn.
02
Drugs
amifostine
03
Conditions
oral mucositis (OM)stomatitis
Beyond the preview
Go deeper on NCT01288625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288625.